Page last updated: 2024-09-03

ilomastat and cgs 27023a

ilomastat has been researched along with cgs 27023a in 1 studies

Compound Research Comparison

Studies
(ilomastat)
Trials
(ilomastat)
Recent Studies (post-2010)
(ilomastat)
Studies
(cgs 27023a)
Trials
(cgs 27023a)
Recent Studies (post-2010) (cgs 27023a)
10304572312

Protein Interaction Comparison

ProteinTaxonomyilomastat (IC50)cgs 27023a (IC50)
Interstitial collagenaseHomo sapiens (human)0.031
72 kDa type IV collagenaseHomo sapiens (human)0.0297
Stromelysin-1Homo sapiens (human)0.0256
Matrix metalloproteinase-9Homo sapiens (human)0.0191
Lethal factorBacillus anthracis1.2
Neutrophil collagenaseHomo sapiens (human)0.0105
Collagenase 3Homo sapiens (human)0.0209
Matrix metalloproteinase-14Homo sapiens (human)0.023

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camodeca, C; Cuffaro, D; Gifford, V; Ito, N; Itoh, Y; Nencetti, S; Nuti, E; Orlandini, E; Rossello, A; Tuccinardi, T1

Other Studies

1 other study(ies) available for ilomastat and cgs 27023a

ArticleYear
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).
    Bioorganic & medicinal chemistry, 2019, 01-01, Volume: 27, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Collagen; Drug Design; Enzyme Activation; Humans; Hydroxamic Acids; Matrix Metalloproteinase 14; Matrix Metalloproteinase Inhibitors; Molecular Dynamics Simulation; Molecular Structure; Protein Multimerization; Sulfonamides

2019